Low-Dose Multi-Drug Combinations
By combining 4–6 chemotherapy drugs at lower doses, Dr. Hirschfeld reduces side effects while maximizing the synergy between medicines to fight cancers more effectively.
Repurposed Medicines
Well-established drugs from other medical fields are safely adapted to oncology, opening new treatment paths for patients who have already exhausted standard options.
Genomic profiling
Each tumor’s unique genetic profile is analyzed, allowing therapies to be precisely matched to the cancer’s biology for greater accuracy and impact.
Data-Driven Off-Label Use
When evidence strongly supports benefit, FDA-approved drugs are used off-label, giving patients earlier access to promising treatments beyond standard protocols.